LAFM Summit on November 10-12, 2026 in Boston, United States

As pharma and biotech face mounting pressure to operate leaner, support increasingly complex science, and maximize the value of their infrastructure investments, the leaders responsible for lab operations, asset management, facilities, and engineering have never played a more strategic role. Rising demand for efficiency, the emergence of AI-enabled operations, workforce restructuring, and renewed investment in U.S. R AND D sites are reshaping how laboratories are designed, managed, and scaled.

Returning to Boston, the 9th Lab Asset and Facility Management Summit is the only forum dedicated to the operational integration layer that enables science to happen. Bringing together 190+ senior leaders from across lab operations, asset lifecycle management, facilities, engineering, and EHS, you’ll gain practical strategies to streamline lab environments, improve asset performance, strengthen cross-functional collaboration, and increase time back to science.

Through interactive discussions, real-world case studies, and peer-to-peer problem solving, you will leave equipped to build smarter, more resilient, and more efficient research environments capable of supporting the next generation of scientific innovation.

URLs:

Tickets: https://go.evvnt.com/3701754-0?pid=10008

Brochure: https://go.evvnt.com/3701754-3?pid=10008

Time: 8:30 AM - 5:00 PM

Prices:

Conference + Focus Day - Drug Developer: USD 3197.00,

Conference Only - Drug Developer: USD 2399.00,

Conference + Focus Day - Service Provider: USD 5297.00,

Conference Only - Service Provider: USD 3799.00

Speakers: Rafael Crespo Site Head of Global Facilities, Engineering and Technology Boehringer Ingelheim, Yekaterina Sharikova Senior Director and Head of Strategy and Research Operations Bristol Myers Squibb, Matthew Greenfield Executive Director - Laboratory Operations and Facilities Eli Lilly and Co., Andrew Kuhn Senior Director - Quality Control Gilead Sciences, Marcelo Kabbach Procurement Solutions Excellence Professionals Gilead Sciences, Steven Chung Senior Associate Scientist, Analytical Operations Gilead Sciences, Sebastian Huerta Garcia Lab Operations Specialist Novartis AG, Marisa Capone Planning and Inventory Management Lead Pfizer, Emily Vanasek Manager, Lab Operations Pfizer, Sahar Rizvi Associate Manager, R and pD Operations Regeneron Pharmaceuticals, Nicole Lee Associate Manager - Asset Management Regeneron Pharmaceuticals, Sadegh majdi Lab Operations Specialist Sanofi, Brandon King Director - Site Operations Sanofi, Lane Milde Director - Global Compound Management Takeda Pharmaceutical, Hermann Ananias da Silva Maintenance and Reliability Lead Takeda Pharmaceutical, Asiem Bhaskar Senior Manager - Laboratory and Facilities Services Arbor Biotechnologies, Inc., Louis King Lab Operations lead Empress Therapeutics, Aleksander Repik Senior Manager, Laboratory and Facilities Operations Ensoma, Oliver Sjahsam Executive Director - Real Estate and Facilities Kardigan, Erika Whyte Senior Director - Strategic Operations Monimoi Therapeutics, Lindsey Straight Senior Manager - Lab Operations QurAlis Corp., Barton Nielsen Associate Director, Facilities Solid Biosciences, Mary Anne Hallacy Program Manager, Facilities Research Support Services University of California, San Francisco, Lois Tolvinski Director - Laboratory Operations Vivodyne, Toni Russo Global Director, Facilities and Workplace Experience ACADIA Pharmaceuticals Inc., Anthony Khoury Associate Director, Global Offices and Workplace Experience ACADIA Pharmaceuticals Inc., Nikolas Denuccio Facilities Manager Alnylam Pharmaceuticals, Keli Rodriguez Associate Director - Facilities and Lab Operations EpiCypher, Morten Munk Senior Program Director, Commercial Fujifilm Corp., Marilyn Sanchez Manager of Lab Operations Seattle Children’s Hospital, David Latshaw Founder and Chief Executive Officer PerkinElmer, Jessica Iannelli Service Operations Manager PerkinElmer, Jim Sweeney Director - Product Management PerkinElmer